Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies

Joseph G. Skeate, Emily J. Pomeroy, Nicholas J. Slipek, Bryan J. Jones, Bryce J. Wick, Jae-Woong Chang, Walker S. Lahr, Erin M. Stelljes, Xiaobai Patrinostro, Blake Barnes, Trevor Zarecki, Joshua B. Krueger, Jacob E. Bridge, Gabrielle M. Robbins, Madeline D. McCormick, John R. Leerar, Kari T. Wenzel, Kathlyn M. Hornberger, Kirsti Walker, Dalton Smedley, David A. Largaespada, Neil Otto, Beau R. Webber, Branden S. Moriarity

Open source

DOI
10.1016/j.ymthe.2024.04.024
Published
2024-06
Container
Molecular Therapy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ymthe.2024.04.024,
  title = {Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies},
  author = {Joseph G. Skeate and Emily J. Pomeroy and Nicholas J. Slipek and Bryan J. Jones and Bryce J. Wick and Jae-Woong Chang and Walker S. Lahr and Erin M. Stelljes and Xiaobai Patrinostro and Blake Barnes and Trevor Zarecki and Joshua B. Krueger and Jacob E. Bridge and Gabrielle M. Robbins and Madeline D. McCormick and John R. Leerar and Kari T. Wenzel and Kathlyn M. Hornberger and Kirsti Walker and Dalton Smedley and David A. Largaespada and Neil Otto and Beau R. Webber and Branden S. Moriarity},
  year = {2024},
  journal = {Molecular Therapy},
  doi = {10.1016/j.ymthe.2024.04.024},
  url = {https://doi.org/10.1016/j.ymthe.2024.04.024}
}

RIS

TY  - JOUR
TI  - Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies
AU  - Joseph G. Skeate
AU  - Emily J. Pomeroy
AU  - Nicholas J. Slipek
AU  - Bryan J. Jones
AU  - Bryce J. Wick
AU  - Jae-Woong Chang
AU  - Walker S. Lahr
AU  - Erin M. Stelljes
AU  - Xiaobai Patrinostro
AU  - Blake Barnes
AU  - Trevor Zarecki
AU  - Joshua B. Krueger
AU  - Jacob E. Bridge
AU  - Gabrielle M. Robbins
AU  - Madeline D. McCormick
AU  - John R. Leerar
AU  - Kari T. Wenzel
AU  - Kathlyn M. Hornberger
AU  - Kirsti Walker
AU  - Dalton Smedley
AU  - David A. Largaespada
AU  - Neil Otto
AU  - Beau R. Webber
AU  - Branden S. Moriarity
PY  - 2024
JO  - Molecular Therapy
DO  - 10.1016/j.ymthe.2024.04.024
UR  - https://doi.org/10.1016/j.ymthe.2024.04.024
ER  - 

APA

Skeate, J. G., Pomeroy, E. J., Slipek, N. J., Jones, B. J., Wick, B. J., Chang, J., Lahr, W. S., Stelljes, E. M., Patrinostro, X., Barnes, B., Zarecki, T., Krueger, J. B., Bridge, J. E., Robbins, G. M., McCormick, M. D., Leerar, J. R., Wenzel, K. T., Hornberger, K. M., Walker, K., Smedley, D., Largaespada, D. A., Otto, N., Webber, B. R., & Moriarity, B. S. (2024). Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.04.024

Source records